Nordson Corporation Reports Second Quarter Fiscal 2024 Results and Updates Annual Guidance
Nordson (Nasdaq: NDSN) reported its fiscal Q2 2024 results with sales of $651 million, matching last year's figure. Net income stood at $118 million, equating to $2.05 per diluted share, a slight decrease from the previous year's $128 million and $2.21 per share. Adjusted earnings were $2.34 per share, down from $2.45. EBITDA remained flat at $203 million, representing 31% of sales.
Segment-wise, Industrial Precision Solutions saw a 9% sales increase to $367 million, while Medical and Fluid Solutions experienced a 2% rise to $169 million. Advanced Technology Solutions, however, faced a 22% decline in sales to $115 million.
Nordson updated its full-year fiscal 2024 guidance to forecast flat to 2% revenue growth, with adjusted EPS expected to range between $9.35 and $9.75. Q3 sales are projected between $645 and $670 million, with adjusted EPS of $2.25 to $2.40.
- Q2 2024 sales of $651 million, comparable to prior year.
- Industrial Precision Solutions sales increased 9% to $367 million.
- Medical and Fluid Solutions sales rose 2% to $169 million.
- EBITDA remained strong at $203 million, 31% of sales.
- Updated full-year revenue guidance to flat to 2% growth over 2023.
- Q3 2024 sales forecasted between $645 and $670 million.
- Q3 2024 adjusted EPS expected between $2.25 and $2.40.
- Net income decreased to $118 million from $128 million.
- Earnings per diluted share down to $2.05 from $2.21.
- Adjusted earnings per share fell to $2.34 from $2.45.
- Organic sales declined by 4%, driven by pressure in electronics product lines.
- Advanced Technology Solutions sales dropped 22% to $115 million.
- Increased interest expense from prior year acquisitions affecting finances.
- Higher selling and administrative expenses due to the ARAG acquisition.
Insights
Nordson Corporation's second quarter fiscal 2024 results reveal a mixed yet stable financial performance. The sales figure of $651 million remains consistent with the same period last year. However, the organic sales decrease of 4% due to ongoing pressure in electronics product lines is a point of concern, counterbalanced by growth in industrial coatings and fluid solutions product lines.
Net income of $118 million, translating to $2.05 per diluted share, marks a decline from the prior year's $128 million ($2.21 per diluted share). This decline reflects increased interest expense from previous acquisitions. The adjusted earnings per share of $2.34, though slightly lower than last year's $2.45, still showcases resilience in profitability management amid higher administrative costs and acquisition-related expenses.
The company's EBITDA of $203 million, or 31% of sales, is in line with the previous year, indicating operational stability. However, investors should note the adjusted guidance for full-year revenue growth, now expected to be flat to 2%, suggesting cautious optimism amid current market pressures. The updated adjusted earnings per share guidance of $9.35 to $9.75 aligns with a prudent outlook given the mixed segment performances and ongoing market uncertainties.
Overall, while there are underlying challenges, the company's diversified portfolio and strong operational focus provide a balanced view of stability and cautious growth potential.
The breakdown of Nordson's second quarter performance across its segments provides valuable insights into the broader market dynamics. The Industrial Precision Solutions (IPS) segment saw a 9% sales increase, driven by both acquisition impact and a 2% organic growth. This indicates strong demand in industrial coatings systems and packaging, reflecting healthy industrial activity.
Conversely, the Advanced Technology Solutions (ATS) segment experienced a significant 22% sales decrease, underscoring the ongoing weakness in electronics-related markets. The decremental margin of 22% and reduced EBITDA margin to 21% highlight the pressure this segment is under.
The Medical and Fluid Solutions (MFS) segment's modest 2% sales growth, with stable EBITDA at 37% of sales, suggests steady but not exceptional performance. The segment's resilience in fluid and interventional solutions is a positive marker amid broader market pressures.
Looking ahead, the company's substantial backlog of $700 million offers a cushion against current market volatilities. The updated guidance indicates a tempered growth outlook, with the electronics cycle and European agriculture sector posing near-term challenges. However, the diversified nature of Nordson's operations and strong recurring revenue streams provide a solid foundation for long-term growth.
Nordson's Advanced Technology Solutions (ATS) segment's performance is critical for understanding the impact of the ongoing electronics cycle. The 22% decrease in sales within this segment is significant, indicating substantial pressure and a slowdown in electronics market demand. This is particularly pertinent as electronics represent a rapidly evolving sector with high sensitivity to market cycles.
The decremental margin of 22% and reduced EBITDA margin from 22% to 21% reflect not only decreased sales but also potentially higher fixed costs and lower utilization rates. This underscores the importance of monitoring market indicators and potential recovery signs in the electronics sector for future performance.
It's notable that Nordson expects these impacts to be temporary, aligning with broader market expectations of a rebound in electronics demand. The strategic focus on innovation and diversification within the segment could position the company well to capitalize on future growth opportunities once the market cycle improves.
Second Quarter:
-
Sales were
$651 million -
Net income was
$118 million -
Earnings per diluted share were
$2.05 -
Adjusted earnings per diluted share were
$2.34 -
EBITDA was
,$203 million 31% of sales
Guidance:
-
Updating full-year fiscal 2024 revenue guidance to the range of flat to
2% growth over record fiscal 2023 and adjusted earnings per diluted share to the range of to$9.35 per share$9.75
Net income was
EBITDA in the second quarter was
Commenting on the Company’s fiscal 2024 second quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “Once again, the teams delivered a solid operating performance, delivering strong gross margins and
Second Quarter Segment Results
Industrial Precision Solutions sales of
Medical and Fluid Solutions sales of
Advanced Technology Solutions sales of
Outlook
The Company is entering the third quarter of fiscal 2024 with approximately
Reflecting on the outlook, Nagarajan continued, “As we move into the second half of fiscal 2024, the positive indicators in the electronics end markets have not yet converted into orders needed to meet our previously issued guidance. We are also experiencing increased pressure from the agriculture cycle in
Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Tuesday, May 21, 2024 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.
The Company’s definition of adjusted earnings excludes acquisition related amortization for both current and historical periods. It is not possible for the Company to identify the amount or significance of future adjustments associated with acquisition and integration costs, restructuring costs, acquisition-related amortization, certain non-operating or income tax items, or other non-routine costs that the Company adjusts in the presentation of adjusted earnings guidance. These items are dependent on future events that are not reasonably estimable at this time. Accordingly, the Company is unable to reconcile without unreasonable effort the forecasted range of adjusted earnings guidance to a comparable GAAP range.
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to,
Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in
NORDSON CORPORATION CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Dollars in thousands except for per-share amounts)
|
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
April 30, 2024 |
|
April 30, 2023 |
||||||||
Sales |
$ |
650,642 |
|
|
$ |
650,165 |
|
|
$ |
1,283,835 |
|
|
$ |
1,260,642 |
|
Cost of sales |
|
284,765 |
|
|
|
298,040 |
|
|
|
569,531 |
|
|
|
579,650 |
|
Gross profit |
|
365,877 |
|
|
|
352,125 |
|
|
|
714,304 |
|
|
|
680,992 |
|
Gross margin % |
|
56.2 |
% |
|
|
54.2 |
% |
|
|
55.6 |
% |
|
|
54.0 |
% |
|
|
|
|
|
|
|
|
||||||||
Selling & administrative expenses |
|
197,261 |
|
|
|
179,618 |
|
|
|
386,253 |
|
|
|
364,266 |
|
Operating profit |
|
168,616 |
|
|
|
172,507 |
|
|
|
328,051 |
|
|
|
316,726 |
|
|
|
|
|
|
|
|
|
||||||||
Interest expense - net |
|
(18,555 |
) |
|
|
(9,475 |
) |
|
|
(38,953 |
) |
|
|
(19,418 |
) |
Other expense - net |
|
(785 |
) |
|
|
(1,405 |
) |
|
|
(1,123 |
) |
|
|
(4,601 |
) |
Income before income taxes |
|
149,276 |
|
|
|
161,627 |
|
|
|
287,975 |
|
|
|
292,707 |
|
|
|
|
|
|
|
|
|
||||||||
Income taxes |
|
31,059 |
|
|
|
34,064 |
|
|
|
60,186 |
|
|
|
60,883 |
|
|
|
|
|
|
|
|
|
||||||||
Net income |
$ |
118,217 |
|
|
$ |
127,563 |
|
|
$ |
227,789 |
|
|
$ |
231,824 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
||||||||
Basic |
|
57,222 |
|
|
|
57,184 |
|
|
|
57,142 |
|
|
|
57,177 |
|
Diluted |
|
57,681 |
|
|
|
57,680 |
|
|
|
57,617 |
|
|
|
57,721 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings per share: |
|
|
|
|
|
|
|
||||||||
Basic earnings |
$ |
2.07 |
|
|
$ |
2.23 |
|
|
$ |
3.99 |
|
|
$ |
4.05 |
|
Diluted earnings |
$ |
2.05 |
|
|
$ |
2.21 |
|
|
$ |
3.95 |
|
|
$ |
4.02 |
|
NORDSON CORPORATION CONSOLIDATED BALANCE SHEETS (Unaudited) (Dollars in thousands)
|
|||||||
|
April 30, 2024 |
|
October 31, 2023 |
||||
Cash and cash equivalents |
$ |
125,446 |
|
$ |
115,679 |
||
Receivables - net |
|
530,283 |
|
|
|
590,886 |
|
Inventories - net |
|
443,578 |
|
|
|
454,775 |
|
Other current assets |
|
86,283 |
|
|
|
67,970 |
|
Total current assets |
|
1,185,590 |
|
|
|
1,229,310 |
|
|
|
|
|
||||
Property, plant and equipment - net |
|
395,595 |
|
|
|
392,846 |
|
Goodwill |
|
2,782,909 |
|
|
|
2,784,201 |
|
Other assets |
|
807,777 |
|
|
|
845,413 |
|
|
$ |
5,171,871 |
|
|
$ |
5,251,770 |
|
|
|
|
|
||||
Notes payable and debt due within one year |
$ |
119,328 |
|
|
$ |
115,662 |
|
Accounts payable and accrued liabilities |
|
416,683 |
|
|
|
466,427 |
|
Total current liabilities |
|
536,011 |
|
|
|
582,089 |
|
|
|
|
|
||||
Long-term debt |
|
1,414,363 |
|
|
|
1,621,394 |
|
Other liabilities |
|
433,226 |
|
|
|
450,227 |
|
Total shareholders' equity |
|
2,788,271 |
|
|
|
2,598,060 |
|
|
$ |
5,171,871 |
|
|
$ |
5,251,770 |
|
|
|
|
|
NORDSON CORPORATION CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Dollars in thousands)
|
|||||||
|
Six Months Ended |
||||||
|
April 30, 2024 |
|
April 30, 2023 |
||||
Cash flows from operating activities: |
|
|
|
||||
Net income |
$ |
227,789 |
|
|
$ |
231,824 |
|
Depreciation and amortization |
|
66,264 |
|
|
|
53,535 |
|
Other non-cash items |
|
10,281 |
|
|
|
11,458 |
|
Changes in working capital |
|
(3,435 |
) |
|
|
(45,857 |
) |
Other |
|
(5,935 |
) |
|
|
36,945 |
|
Net cash provided by operating activities |
|
294,964 |
|
|
|
287,905 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Additions to property, plant and equipment |
|
(21,907 |
) |
|
|
(15,349 |
) |
Acquisition of businesses, net of cash acquired |
|
— |
|
|
|
(377,843 |
) |
Other - net |
|
6,730 |
|
|
|
39 |
|
Net cash used in investing activities |
|
(15,177 |
) |
|
|
(393,153 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Issuance (repayment) of long-term debt |
|
(204,372 |
) |
|
|
184,617 |
|
Repayment of finance lease obligations |
|
(2,881 |
) |
|
|
(2,775 |
) |
Dividends paid |
|
(77,796 |
) |
|
|
(74,463 |
) |
Issuance of common shares |
|
27,219 |
|
|
|
11,808 |
|
Purchase of treasury shares |
|
(7,927 |
) |
|
|
(54,365 |
) |
Net cash provided (used) in financing activities |
|
(265,757 |
) |
|
|
64,822 |
|
|
|
|
|
||||
Effect of exchange rate change on cash: |
|
(4,263 |
) |
|
|
6,042 |
|
Net change in cash and cash equivalents |
|
9,767 |
|
|
|
(34,384 |
) |
|
|
|
|
||||
Cash and cash equivalents: |
|
|
|
||||
Beginning of period |
|
115,679 |
|
|
|
163,457 |
|
End of period |
$ |
125,446 |
|
|
$ |
129,073 |
|
|
|
|
|
NORDSON CORPORATION SALES BY GEOGRAPHIC SEGMENT (Unaudited) (Dollars in thousands)
|
|||||||||||||||||||
|
Three Months Ended |
|
Sales Variance |
||||||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
Organic |
|
Acquisitions |
|
Currency |
|
Total |
||||||||
SALES BY SEGMENT |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Industrial Precision Solutions |
$ |
366,991 |
|
$ |
335,807 |
|
1.5 |
% |
|
8.6 |
% |
|
(0.8 |
)% |
|
9.3 |
% |
||
Medical and Fluid Solutions |
|
168,966 |
|
|
|
166,526 |
|
|
1.8 |
% |
|
— |
% |
|
(0.3 |
)% |
|
1.5 |
% |
Advanced Technology Solutions |
|
114,685 |
|
|
|
147,832 |
|
|
(21.6 |
)% |
|
— |
% |
|
(0.8 |
)% |
|
(22.4 |
)% |
Total sales |
$ |
650,642 |
|
|
$ |
650,165 |
|
|
(3.7 |
)% |
|
4.5 |
% |
|
(0.7 |
)% |
|
0.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SALES BY GEOGRAPHIC REGION |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
$ |
294,428 |
|
|
$ |
278,731 |
|
|
2.9 |
% |
|
2.3 |
% |
|
0.4 |
% |
|
5.6 |
% |
|
|
182,070 |
|
|
|
167,904 |
|
|
(4.4 |
)% |
|
12.5 |
% |
|
0.3 |
% |
|
8.4 |
% |
|
|
174,144 |
|
|
|
203,530 |
|
|
(12.3 |
)% |
|
0.7 |
% |
|
(2.8 |
)% |
|
(14.4 |
)% |
Total sales |
$ |
650,642 |
|
|
$ |
650,165 |
|
|
(3.7 |
)% |
|
4.5 |
% |
|
(0.7 |
)% |
|
0.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Six Months Ended |
|
Sales Variance |
||||||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
Organic |
|
Acquisitions |
|
Currency |
|
Total |
||||||||
SALES BY SEGMENT |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Industrial Precision Solutions |
$ |
721,538 |
|
|
$ |
647,353 |
|
|
1.9 |
% |
|
9.6 |
% |
|
— |
% |
|
11.5 |
% |
Medical and Fluid Solutions |
|
328,492 |
|
|
|
320,813 |
|
|
2.4 |
% |
|
— |
% |
|
— |
% |
|
2.4 |
% |
Advanced Technology Solutions |
|
233,805 |
|
|
|
292,476 |
|
|
(19.6 |
)% |
|
— |
% |
|
(0.5 |
)% |
|
(20.1 |
)% |
Total sales |
$ |
1,283,835 |
|
|
$ |
1,260,642 |
|
|
(2.9 |
)% |
|
4.9 |
% |
|
(0.2 |
)% |
|
1.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
SALES BY GEOGRAPHIC REGION |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
$ |
568,440 |
|
|
$ |
543,610 |
|
|
1.3 |
% |
|
2.8 |
% |
|
0.5 |
% |
|
4.6 |
% |
|
|
361,380 |
|
|
|
330,843 |
|
|
(5.7 |
)% |
|
13.4 |
% |
|
1.5 |
% |
|
9.2 |
% |
|
|
354,015 |
|
|
|
386,189 |
|
|
(6.7 |
)% |
|
0.7 |
% |
|
(2.3 |
)% |
|
(8.3 |
)% |
Total sales |
$ |
1,283,835 |
|
|
$ |
1,260,642 |
|
|
(2.9 |
)% |
|
4.9 |
% |
|
(0.2 |
)% |
|
1.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited) (Dollars in thousands)
|
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
April 30, 2024 |
|
April 30, 2023 |
||||||||
Net income |
$ |
118,217 |
|
$ |
127,563 |
|
$ |
227,789 |
|
$ |
231,824 |
||||
Income taxes |
|
31,059 |
|
|
|
34,064 |
|
|
|
60,186 |
|
|
|
60,883 |
|
Interest expense - net |
|
18,555 |
|
|
|
9,475 |
|
|
|
38,953 |
|
|
|
19,418 |
|
Other expense - net |
|
785 |
|
|
|
1,405 |
|
|
|
1,123 |
|
|
|
4,601 |
|
Depreciation and amortization |
|
32,720 |
|
|
|
27,100 |
|
|
|
66,264 |
|
|
|
53,535 |
|
Inventory step-up amortization (1) |
|
— |
|
|
|
— |
|
|
|
2,944 |
|
|
|
4,306 |
|
Severance and other |
|
2,078 |
|
|
|
3,439 |
|
|
|
2,078 |
|
|
|
3,439 |
|
Acquisition-related costs (1) |
|
— |
|
|
|
— |
|
|
|
597 |
|
|
|
5,989 |
|
EBITDA (non-GAAP) (2) |
$ |
203,414 |
|
|
$ |
203,046 |
|
|
$ |
399,934 |
|
|
$ |
383,995 |
|
(1) |
Represents fees, severance and non-cash inventory charges associated with acquisitions. |
(2) |
EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization. |
NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited) (Dollars in thousands)
|
|||||||||||||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
April 30, 2024 |
|
April 30, 2023 |
||||||||||||||||||||
SALES BY SEGMENT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Industrial Precision Solutions |
$ |
366,991 |
|
|
|
|
$ |
335,807 |
|
|
|
|
$ |
721,538 |
|
|
|
|
$ |
647,353 |
|
|
|
||||
Medical and Fluid Solutions |
|
168,966 |
|
|
|
|
|
166,526 |
|
|
|
|
|
328,492 |
|
|
|
|
|
320,813 |
|
|
|
||||
Advanced Technology Solutions |
|
114,685 |
|
|
|
|
|
147,832 |
|
|
|
|
|
233,805 |
|
|
|
|
|
292,476 |
|
|
|
||||
Total sales |
$ |
650,642 |
|
|
|
|
$ |
650,165 |
|
|
|
|
$ |
1,283,835 |
|
|
|
|
$ |
1,260,642 |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
OPERATING PROFIT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Industrial Precision Solutions |
$ |
117,831 |
|
|
|
|
$ |
111,773 |
|
|
|
|
$ |
226,195 |
|
|
|
|
$ |
214,093 |
|
|
|
||||
Medical and Fluid Solutions |
|
48,993 |
|
|
|
|
|
47,922 |
|
|
|
|
|
95,093 |
|
|
|
|
|
87,307 |
|
|
|
||||
Advanced Technology Solutions |
|
18,784 |
|
|
|
|
|
26,090 |
|
|
|
|
|
37,822 |
|
|
|
|
|
43,053 |
|
|
|
||||
Corporate |
|
(16,992 |
) |
|
|
|
|
(13,278 |
) |
|
|
|
|
(31,059 |
) |
|
|
|
|
(27,727 |
) |
|
|
||||
Total operating profit |
$ |
168,616 |
|
|
|
|
$ |
172,507 |
|
|
|
|
$ |
328,051 |
|
|
|
|
$ |
316,726 |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
OPERATING PROFIT ADJUSTMENTS (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Industrial Precision Solutions |
$ |
— |
|
|
|
|
$ |
— |
|
|
|
|
$ |
3,541 |
|
|
|
|
$ |
— |
|
|
|
||||
Medical and Fluid Solutions |
|
— |
|
|
|
|
|
1,479 |
|
|
|
|
|
— |
|
|
|
|
|
1,479 |
|
|
|
||||
Advanced Technology Solutions |
|
2,078 |
|
|
|
|
|
1,960 |
|
|
|
|
|
2,078 |
|
|
|
|
|
12,255 |
|
|
|
||||
Total adjustments |
$ |
2,078 |
|
|
|
|
$ |
3,439 |
|
|
|
|
$ |
5,619 |
|
|
|
|
$ |
13,734 |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
DEPRECIATION & AMORTIZATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Industrial Precision Solutions |
$ |
13,920 |
|
|
|
|
$ |
7,285 |
|
|
|
|
$ |
28,300 |
|
|
|
|
$ |
14,130 |
|
|
|
||||
Medical and Fluid Solutions |
|
13,564 |
|
|
|
|
|
13,683 |
|
|
|
|
|
27,269 |
|
|
|
|
|
27,308 |
|
|
|
||||
Advanced Technology Solutions |
|
3,284 |
|
|
|
|
|
4,010 |
|
|
|
|
|
6,725 |
|
|
|
|
|
7,822 |
|
|
|
||||
Corporate |
|
1,952 |
|
|
|
|
|
2,122 |
|
|
|
|
|
3,970 |
|
|
|
|
|
4,275 |
|
|
|
||||
Total depreciation & amortization |
$ |
32,720 |
|
|
|
|
$ |
27,100 |
|
|
|
|
$ |
66,264 |
|
|
|
|
$ |
53,535 |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
EBITDA (NON-GAAP) (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Industrial Precision Solutions |
$ |
131,751 |
|
|
36 |
% |
|
$ |
119,058 |
|
|
35 |
% |
|
$ |
258,036 |
|
|
36 |
% |
|
$ |
228,223 |
|
|
35 |
% |
Medical and Fluid Solutions |
|
62,557 |
|
|
37 |
% |
|
|
63,084 |
|
|
38 |
% |
|
|
122,362 |
|
|
37 |
% |
|
|
116,094 |
|
|
36 |
% |
Advanced Technology Solutions |
|
24,146 |
|
|
21 |
% |
|
|
32,060 |
|
|
22 |
% |
|
|
46,625 |
|
|
20 |
% |
|
|
63,130 |
|
|
22 |
% |
Corporate |
|
(15,040 |
) |
|
|
|
|
(11,156 |
) |
|
|
|
|
(27,089 |
) |
|
|
|
|
(23,452 |
) |
|
|
||||
Total EBITDA |
$ |
203,414 |
|
|
31 |
% |
|
$ |
203,046 |
|
|
31 |
% |
|
$ |
399,934 |
|
|
31 |
% |
|
$ |
383,995 |
|
|
30 |
% |
(1) |
Represents severance as well as fees and non-cash inventory charges associated with acquisitions. |
(2) |
EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization. |
NORDSON CORPORATION RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited) (Dollars in thousands)
|
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
April 30, 2024 |
|
April 30, 2023 |
|
April 30, 2024 |
|
April 30, 2023 |
||||||||
GAAP AS REPORTED |
|
|
|
|
|
|
|
||||||||
Operating profit |
$ |
168,616 |
|
|
$ |
172,507 |
|
|
$ |
328,051 |
|
|
$ |
316,726 |
|
Other / interest expense - net |
|
(19,340 |
) |
|
|
(10,880 |
) |
|
|
(40,076 |
) |
|
|
(24,019 |
) |
Net income |
|
118,217 |
|
|
|
127,563 |
|
|
|
227,789 |
|
|
|
231,824 |
|
Diluted earnings per share |
$ |
2.05 |
|
|
$ |
2.21 |
|
|
$ |
3.95 |
|
|
$ |
4.02 |
|
|
|
|
|
|
|
|
|
||||||||
Shares outstanding - diluted |
|
57,681 |
|
|
|
57,680 |
|
|
|
57,617 |
|
|
|
57,721 |
|
|
|
|
|
|
|
|
|
||||||||
OPERATING PROFIT ADJUSTMENTS |
|
|
|
|
|
|
|
||||||||
Inventory step-up amortization |
$ |
— |
|
|
$ |
— |
|
|
$ |
2,944 |
|
|
$ |
4,306 |
|
Acquisition-related costs |
|
— |
|
|
|
— |
|
|
|
597 |
|
|
|
5,989 |
|
Severance and other |
|
2,078 |
|
|
|
3,439 |
|
|
|
2,078 |
|
|
|
3,439 |
|
|
|
|
|
|
|
|
|
||||||||
ACQUISITION AMORTIZATION OF INTANGIBLES |
$ |
18,823 |
|
|
$ |
14,044 |
|
|
|
38,210 |
|
|
|
27,917 |
|
|
|
|
|
|
|
|
|
||||||||
Total adjustments |
$ |
20,901 |
|
|
$ |
17,483 |
|
|
$ |
43,829 |
|
|
$ |
41,651 |
|
|
|
|
|
|
|
|
|
||||||||
Adjustments net of tax |
$ |
16,556 |
|
|
$ |
13,798 |
|
|
$ |
34,669 |
|
|
$ |
32,988 |
|
EPS effect of adjustments and other discrete tax items |
$ |
0.29 |
|
|
$ |
0.24 |
|
|
$ |
0.60 |
|
|
$ |
0.57 |
|
|
|
|
|
|
|
|
|
||||||||
NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE |
|
|
|
|
|
|
|
||||||||
Adjusted Net income (1) |
$ |
134,773 |
|
|
$ |
141,361 |
|
|
$ |
262,458 |
|
|
$ |
264,812 |
|
Adjusted Diluted earnings per share (2) |
$ |
2.34 |
|
|
$ |
2.45 |
|
|
$ |
4.55 |
|
|
$ |
4.59 |
|
(1) |
Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items. |
(2) |
Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items. |
Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240520510596/en/
Lara Mahoney
Vice President, Investor Relations & Corporate Communications
440.204.9985
Lara.Mahoney@nordson.com
Source: Nordson Corporation
FAQ
What were Nordson's Q2 2024 sales?
What was Nordson's Q2 2024 net income?
How did Nordson's Q2 2024 earnings per share compare to last year?
What is Nordson's updated full-year fiscal 2024 revenue guidance?
What was Nordson's Q2 2024 EBITDA?
What is Nordson's Q3 2024 sales forecast?
What was the impact of the ARAG acquisition on Nordson's Q2 2024 results?
How did Advanced Technology Solutions perform in Q2 2024 for Nordson?
What are Nordson's projected Q3 2024 adjusted EPS?